Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Isoflurane + Remifentanil versus Propofol + Remifentanil for blood pressure control and surgeon satisfaction in rhinoplasty
IRCT20141009019470N95Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Feb 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial comparing Isoflurane + Remifentanil with Propofol + Remifentanil (2 arms). Primary endpoints: Intraoperative blood pressure control and Surgeon satisfaction. Started Feb 2020; status: completed.
02
Drugs
isofluranepropofolremifentanil
Beyond the preview
Go deeper on IRCT20141009019470N95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141009019470N95.